Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Yues International Holdings Group Limited ( (HK:1529) ) just unveiled an update.
Yues International Holdings Group Limited has appointed Mr. Yueh Chueh-Hsin as an executive director effective from December 8, 2025. Mr. Yueh, a 14th-generation successor of the Le Family Tong Ren Tang traditional pharmacy, brings extensive experience in TCM research and the health industry. His appointment is expected to enhance the company’s strategic planning and investment decisions, especially in integrating heritage brands with modern biotechnology and digital technologies. This move could strengthen the company’s market position and offer new opportunities for growth and innovation in the TCM sector.
The most recent analyst rating on (HK:1529) stock is a Hold with a HK$0.53 price target. To see the full list of analyst forecasts on Yues International Holdings Group Limited stock, see the HK:1529 Stock Forecast page.
More about Yues International Holdings Group Limited
Yues International Holdings Group Limited operates in the traditional Chinese medicine (TCM) and health and wellness industry. The company focuses on the formulation development and quality management of Chinese patent medicines and ‘medicine-food homology’ products, as well as the establishment and operation of GMP-compliant pharmaceutical manufacturing facilities.
Average Trading Volume: 153,574
Technical Sentiment Signal: Hold
Current Market Cap: HK$340.2M
See more insights into 1529 stock on TipRanks’ Stock Analysis page.